Trials / Sponsors / Prestige Biopharma Limited
Prestige Biopharma Limited
Industry · 6 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | First in Human Phase1/2a Clinical Trial of Anti-PAUF Monoclonal Antibody PBP1510 in Patients With Pancreatic C Pancreatic Cancer | Phase 1 / Phase 2 | 2023-06-05 |
| Recruiting | To Compare the Pharmacokinetics and Safety of PBP1502 and Humira in Healthy Subjects Healthy Volunteers | Phase 1 | 2022-03-30 |
| Active Not Recruiting | A Trial to Compare the Efficacy, Safety, Pharmacokinetics and Immunogenicity of HD204 to Avastin® in Advanced Lung Cancer, Non-small Cell Lung Cancer | Phase 3 | 2019-11-15 |
| Completed | A Study to Demonstrate the Equivalent Pharmacokinetic Properties of a Single Intravenous Dose of HD201 and EU- Healthy Volunteers | Phase 1 | 2019-04-01 |
| Completed | To Demonstrate Equivalent Pharmacokinetic Properties of HD204 and Bevacizumab (Avastin®) in Healthy Male Subje Healthy Volunteers | Phase 1 | 2018-09-19 |
| Completed | A Phase III Trial to Compare the Efficacy, Safety and Pharmacokinetics of HD201 to Herceptin® in HER2+ Early B HER2 Positive Breast Cancer | Phase 3 | 2018-02-19 |